We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

8 hedge funds and large institutions have $28K invested in PDL BioPharma, Inc. in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 8 → 8 (0)

0% more capital invested

Capital invested by funds: $28K → $28K ($0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
8
Holders Change
–
Holders Change %
0%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

PDLI Hedge Fund Activity: Q4 2025 in Review

8 of the 8,270 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q4 2025, worth a combined $28K — unchanged from a quarter earlier.

Fund positioning in PDLI was balanced in Q4 2025: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.

  • 8 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q4 2025, unchanged from Q3 2025.
  • Funds reported $28K of PDL BioPharma, Inc. stock for Q4 2025, unchanged quarter-over-quarter.
  • 1 fund opened new PDL BioPharma, Inc. positions in Q4 2025 and 1 closed out, a net change of 0 holders.

Based on aggregated 13F filings for Q4 2025.